<DOC>
	<DOCNO>NCT00574795</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , immunogenicity 13-valent pneumococcal conjugate vaccine ( 13vPnC ) infant Japanese descent .</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Healthy Japanese Infants</brief_title>
	<detailed_description />
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2 6 monthold infant Available entire study period Previous vaccination license investigational pneumococcal vaccine . Previous anaphylactic reaction vaccine vaccinerelated component . Contraindication vaccination pneumococcal conjugate vaccine . Bleeding diathesis condition associate prolonged bleeding time would contraindicate type injection . Known suspected immune deficiency suppression .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>